Literature DB >> 21927567

18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.

Youn Mi Son1, Joon Young Choi, Cheol Hee Bak, Miju Cheon, Young Eun Kim, Kyung-Han Lee, Byung-Tae Kim.   

Abstract

We report here on a rare case of primary AL hepatic amyloidosis associated with multiple myeloma in a 64-year-old woman. The patient was referred for evaluating her progressive jaundice and right upper quadrant pain. (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT) showed diffusely and markedly increased (18)F-FDG uptake in the liver. Although there have been several case studies showing positive (18)F-FDG uptake in pulmonary amyloidosis, to the best of our knowledge, the (18)F-FDG PET/CT findings of hepatic amyloidosis or primary hepatic amyloidosis associated with multiple myeloma have not been reported previously.

Entities:  

Keywords:  18F-FDG PET; Amyloidosis; Liver; Multiple Myeloma

Mesh：

Substances：

Year:  2011        PMID： 21927567      PMCID： PMC3168807          DOI： 10.3348/kjr.2011.12.5.634

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN： 1229-6929            Impact factor:   3.500


  14 in total

1.  Hepatic failure due to myeloma-associated amyloidosis.

Authors:  M Okabe; G H Choi; M Kudo; H Nakaya; A Kishimoto; H Suzuki; T Miyagishima
Journal:  J Gastroenterol       Date:  1998-12       Impact factor: 7.527

2.  Amyloidosis: an overview.

Authors:  P P Scott; W W Scott; S S Siegelman
Journal:  Semin Roentgenol       Date:  1986-04       Impact factor: 0.800

3.  Magnetic resonance imaging in primary amyloidosis.

Authors:  L Benson; A Hemmingsson; A Ericsson; B Jung; G Sperber; K A Thuomas; P Westermark
Journal:  Acta Radiol       Date:  1987 Jan-Feb       Impact factor: 1.990

4.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

5.  Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT.

Authors:  Ji Hyoung Seo; Sang Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Lung Cancer       Date:  2010-03       Impact factor: 5.705

6.  Hepatic amyloidosis: clinical appraisal in 77 patients.

Authors:  M A Gertz; R A Kyle
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

7.  Technetium-99m (V) DMSA uptake in amyloidosis.

Authors:  H Ohta; K Endo; T Kanoh; J Konishi; H Kotoura
Journal:  J Nucl Med       Date:  1989-12       Impact factor: 10.057

Review 8.  CT evaluation of amyloidosis: spectrum of disease.

Authors:  B A Urban; E K Fishman; S M Goldman; W W Scott; B Jones; R L Humphrey; R H Hruban
Journal:  Radiographics       Date:  1993-11       Impact factor: 5.333

Review 9.  Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL)

Authors:  T Yamamoto; N Maeda; H Kawasaki
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

10.  Abdominal amyloidosis: spectrum of radiological findings.

Authors:  S H Kim; J K Han; K H Lee; H J Won; K W Kim; J S Kim; C H Park; B I Choi
Journal:  Clin Radiol       Date:  2003-08       Impact factor: 2.350
View more
  9 in total

1.  Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis.

Authors:  Joo Hee Lee; Ga Yeon Lee; Seok Jin Kim; Ki Hyun Kim; Eun-Seok Jeon; Kyung-Han Lee; Byung-Tae Kim; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2015-05-13

2.  Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review.

Authors:  Jian Zhang; Chuxiao Shao; Jinde Zhu; Chaoyong Tu; Xinliang Lv
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

3.  Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.

Authors:  Andor W J M Glaudemans; Riemer H J A Slart; Walter Noordzij; Rudi A J O Dierckx; Bouke P C Hazenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-09       Impact factor: 9.236

4.  Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging.

Authors:  Ryogo Minamimoto; Kazuo Kubota; Kenji Ishii; Miyako Morooka; Momoko Okasaki; Yoko Miyata; Kazuhiko Nakajima; Takashi Sato; Toru Igari; Risen Hirai; Osamu Okazaki
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

5.  Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass.

Authors:  Sebastiano Cicco; Antonio G Solimando; Patrizia Leone; Stefano Battaglia; Roberto Ria; Angelo Vacca; Vito Racanelli
Journal:  Case Rep Hematol       Date:  2018-10-17

6.  Amyloidosis Associated Kidney Failure with Gross Hypermetabolic Intra-abdominal Mass

Authors:  Zehra Pınar Koç; Pınar Pelin Özcan; Kenan Turgutalp; Kaan Esen; Tuğba Kara
Journal:  Mol Imaging Radionucl Ther       Date:  2020-02-17

7.  RE: imaging features of hepato-splenic amyloidosis at PET/CT.

Authors:  Pier Paolo Mainenti
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

8.  18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.

Authors:  Akinobu Tawada; Tatsuo Kanda; Takashi Oide; Toshio Tsuyuguchi; Fumio Imazeki; Yukio Nakatani; Osamu Yokosuka
Journal:  Int Med Case Rep J       Date:  2014-06-20

9.  Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma.

Authors:  Maria E S Takahashi; Camila Mosci; Edna M Souza; Sérgio Q Brunetto; Elba Etchebehere; Allan O Santos; Mariana R Camacho; Eliana Miranda; Mariana C L Lima; Barbara J Amorim; Carmino de Souza; Fernando V Pericole; Irene Lorand-Metze; Celso D Ramos
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.